<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02517775</url>
  </required_header>
  <id_info>
    <org_study_id>14-012</org_study_id>
    <nct_id>NCT02517775</nct_id>
  </id_info>
  <brief_title>Effects of Cranberry Consumption in Vascular Function in Healthy Individuals</brief_title>
  <acronym>Cranberry</acronym>
  <official_title>Intake and Time-dependent Effects of Cranberry (Poly)Phenol Consumption in Vascular Function in Healthy Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Cranberry Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Accumulating evidence from epidemiological and human intervention studies indicates that the
      cardiovascular health benefits of diets rich in fruits and vegetables are (in part) related
      to their (poly)phenol content. Cranberries are rich in (poly)phenols compounds, in particular
      anthocyanins, but also phenolic acids. At present, a small number of randomized controlled
      trials investigating the effects of berry (poly)phenols on validated surrogate markers of
      cardiovascular disease risk has shown promising results. However, to date, very few human
      studies have specifically investigated the effects of cranberry (poly)phenols on
      cardiovascular function in healthy subjects. To our knowledge, no study has investigated the
      time and intake-dependent effect of cranberry consumption on vascular function in healthy
      subjects. This information is necessary for the planning of long-term studies aiming to
      assess the potential beneficial effects of cranberries, using optimal amounts at optimal time
      points. Therefore, this study aims to investigate the potential role of cranberry
      (poly)phenols in the modulation of vascular function by monitoring changes in vascular
      function together with the major (poly)phenol derivatives/metabolites in plasma and urine.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>Baseline, on week 1, 2, 3, 4 and 5 postconsumption</time_frame>
    <description>measured by Flow mediated dilation at 1, 2, 4, 6 and 8 hours after intake</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pulse wave velocity</measure>
    <time_frame>Baseline, on week 1, 2, 3, 4 and 5 postconsumption</time_frame>
    <description>measured by SphygmoCor at 0, 1, 2, 4, 6 and 8 hours after intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central blood pressure</measure>
    <time_frame>Baseline, on week 1, 2, 3, 4 and 5 postconsumption</time_frame>
    <description>measured by SphygmoCor at 0, 1.5, 4, 6 and 8 hours after intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral blood pressure</measure>
    <time_frame>Baseline, on week 1, 2, 3, 4 and 5 postconsumption</time_frame>
    <description>measured by automatic sphygmomanometer at 0, 1, 2, 4, 6 and 8 hours after intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Baseline, on week 1, 2, 3, 4 and 5 postconsumption</time_frame>
    <description>measured by SphygmoCor 0, 1, 2, 4, 6 and 8 hours after intake</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Plasma (poly)phenol metabolites</measure>
    <time_frame>Baseline, on week 1, 2, 3, 4 and 5 postconsumption</time_frame>
    <description>measured by ultra-performance liquid chromatography quadrupole time of flight mass spectrometry (UPLC-Q-TOF MS) at 0,1, 2, 4, 6, 8 and 24 hours after intake</description>
  </other_outcome>
  <other_outcome>
    <measure>Urinary (poly)phenol metabolites</measure>
    <time_frame>Baseline, on week 1, 2, 3, 4 and 5 postconsumption</time_frame>
    <description>measured by ultra-performance liquid chromatography quadrupole time of flight mass spectrometry (UPLC-Q-TOF MS) at 0, 8 and 24 hours after intake</description>
  </other_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy Men</condition>
  <arm_group>
    <arm_group_label>Cranberry 320</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary Supplement: Cranberry beverage with 320 mg of (poly)phenols Acute intake of 500 mL (1x daily)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cranberry 640</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary Supplement: Cranberry beverage with 640 mg of (poly)phenols Acute intake of 500 mL (1x daily)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cranberry 960</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary Supplement: Cranberry beverage with 960 mg of (poly)phenols Acute intake of 500 mL (1x daily)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cranberry 1280</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary Supplement: Cranberry beverage with 1280 mg of (poly)phenols Acute intake of 500 mL (1x daily)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cranberry 1600</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary Supplement: Cranberry beverage with 1600 mg of (poly)phenols Acute intake of 500 mL (1x daily)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cranberry deprived supplement</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo comparator: Cranberry deprived supplement Acute intake of 500 mL (1x daily)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cranberry 320</intervention_name>
    <description>Dietary Supplement: Cranberry beverage with 320 mg of (poly)phenols Acute intake of 500 mL (1x daily)</description>
    <arm_group_label>Cranberry 320</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cranberry 640</intervention_name>
    <description>Dietary Supplement: Cranberry beverage with 640 mg of (poly)phenols Acute intake of 500 mL (1x daily)</description>
    <arm_group_label>Cranberry 640</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cranberry 960</intervention_name>
    <description>Dietary Supplement: Cranberry beverage with 960 mg of (poly)phenols Acute intake of 500 mL (1x daily)</description>
    <arm_group_label>Cranberry 960</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cranberry 1280</intervention_name>
    <description>Dietary Supplement: Cranberry beverage with 1280 mg of (poly)phenols Acute intake of 500 mL (1x daily)</description>
    <arm_group_label>Cranberry 1280</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cranberry 1600</intervention_name>
    <description>Dietary Supplement: Cranberry beverage with 1600 mg of (poly)phenols Acute intake of 500 mL (1x daily)</description>
    <arm_group_label>Cranberry 1600</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cranberry deprived supplement</intervention_name>
    <description>Cranberry deprived supplement Acute intake of 500 mL (1x daily)</description>
    <arm_group_label>Cranberry deprived supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy male subjects without clinical signs or symptoms of cardiovascular disease

        Exclusion Criteria:

          -  cardiovascular disease

          -  acute inflammation

          -  cardiac arrhythmia

          -  renal failure

          -  heart failure (NYHA II-IV)

          -  diabetes mellitus

          -  C-reactive protein &gt; 05 mg/dL

          -  malignant disease

          -  cranberry allergy/intolerance

          -  hypotension (≤100 / 60 mm Hg)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ana Rodriguez-Mateos, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonology and Vascular Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Heiss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonology and Vascular Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonary Disease and Vascular Medicine, University Hospital Duesseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2015</study_first_submitted>
  <study_first_submitted_qc>August 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2015</study_first_posted>
  <last_update_submitted>November 2, 2015</last_update_submitted>
  <last_update_submitted_qc>November 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Division of Cardiology, Pulmonary Diseases, Vascular Medicine</investigator_title>
  </responsible_party>
  <keyword>polyphenols</keyword>
  <keyword>vascular function</keyword>
  <keyword>endothelial function</keyword>
  <keyword>cranberry</keyword>
  <keyword>healthy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

